See also this year's filing and all EDGAR filings for this company.
PDF Report 0001557746_2018_Aclaris_Therapeutics_Inc.pdf
Logs
Graph
Absolute values for 0001557746, Aclaris Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 200,221,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 25,853,000 |
| 2 | PropertyPlantAndEquipmentNet | 2,159,000 |
| 3 | remainder_Assets | 15,276,000 |
| 4 | LiabilitiesCurrent | 12,762,000 |
| 5 | LiabilitiesNoncurrent | 558,000 |
| 6 | remainder_Liabilities | 4,927,000 |
| 7 | CostOfGoodsAndServicesSold | 1,207,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 33,109,000 |
| 9 | ResearchAndDevelopmentExpense | 39,790,000 |
| 10 | remainder_Expenses | -1,830,000 |
| 11 | remainder_Revenues | 1,683,000 |
| 12 | remainder_NetIncome | 2,070,000 |
| 13 | remainder_ComprehensiveNetIncome | 23,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 243,509,000 |
| 1 | Liabilities | 18,247,000 |
| 2 | Expenses | 72,276,000 |
| 3 | Revenues | 1,683,000 |
| 4 | StockholdersEquity | 225,262,000 |
| 5 | NetIncome | -68,523,000 |
| 6 | ComprehensiveNetIncome | -68,511,500 |
| 7 | BaseVar | 168,904,000 |
| 8 | EconomicCapitalRatio | 2.44 |
Edgar->Model Mapping
Feature Distribution
Change over Time
